1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Newly Diagnosed: new trials by email Literature Review of Newly Diagnosed trials Research Report on Newly Diagnosed
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ponatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph+ ALL Ponatinib 15 MG Oral Tablet - Acute Lymphoblastic Leukemia, Adult, Ph+ ALL | Phase 2 | Terminated | Institute of Hematology and Blood Transfusion, Czech Republic | 4 | 2021-02-16 | 2024-08-14 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Institute of Hematology and Blood Transfusion, Czech Republic (1)
Czechia (1)
Cyril Salek, MD (1)